Clinical phase III trials of the Bharat Biotech's COVID-19 nasal vaccine completed
August 6, 2026
  • Read Ecopy
  • Circulation
  • Advertise
  • Careers
  • About Us
  • Contact Us
Android AppiPhone AppArattai
Organiser
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
  • Editorial
  • International
  • Opinion
  • RSS @ 100
  • More
    • Op Sindoor
    • Analysis
    • Sports
    • Defence
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
  • Subscribe
    • Subscribe Print Edition
    • Subscribe Ecopy
    • Read Ecopy
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
  • Editorial
  • International
  • Opinion
  • RSS @ 100
  • More
    • Op Sindoor
    • Analysis
    • Sports
    • Defence
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
  • Subscribe
    • Subscribe Print Edition
    • Subscribe Ecopy
    • Read Ecopy
Organiser
  • Home
  • Bharat
  • World
  • Operation Sindoor
  • Editorial
  • Analysis
  • Opinion
  • Culture
  • Defence
  • International Edition
  • RSS @ 100
  • Magazine
  • Read Ecopy
Home Bharat

Clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine completed

Talking about the Vivatech 2022, Krishna said that this is really great achievement for India, building a brand name in France.

WEBDESKWEBDESK
Jun 19, 2022, 12:20 pm IST
inBharat
Follow on Google News
Facebook
Twitter
WhatsAppTelegramEmail

Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data to the Drugs Controller General of India (DCGI) next month.

In an exclusive interview with ANI, Dr Ella said, “We just completed a clinical trial, a data analysis is going on. Next month, we will submit the data to the regulatory agency. If everything is okay, then we will get permission to launch and it will be the world’s first clinically proven nasal COVID-19 vaccine”.

Krishna was in Paris as a speaker at Viva Technology 2022 where India was declared country of the year. India’s drug controller had in January this year given permission to Bharat Biotech to conduct standalone phase III trials on its COVID-19 nasal vaccine. On the booster dose of COVID-19, Krishna said that those who had taken the second dose must take the booster dose.

“Booster dose of vaccine gives immunity. I always say the booster dose is a miracle dose for every vaccination. Even in children first, two doses don’t give much immunity, but the third dose gives an amazing response to the child. The same thing for adults also. The third dose is very important for adults. COVID-19 can’t be eradicated 100 per cent. It will be there and we have to live with it and handle it and more intelligently how to control it,” he said.

Talking about the Vivatech 2022, Krishna said that this is really great achievement for India, building a brand name in France. “I am glad to say 65 startups from India, under NITI Aayog they all came, showing that technology to a lot of people, what India can do, how India can innovate for the world. They are vibrant because I was a startup in 1997.”

He said that earlier United States was the centre of startups but for the first time Indians are getting exposure in France. “I am so happy to say the French government is very practical. They are really encouraging India and with truthfully a good heart. Again, they are really pushing how more the government can work together. How about the country’s startups can work together?”, he said.

“How government policies can create an ecosystem that is scalable, even French President Macron was talking about how to scale it up between the two partnerships, how to scale up for globe and the digitalization all that is talking about infrastructure, digitalization all that they are talking and that is a good sign between the two countries and the first time French is coming closer to India,” he added.

 

Topics: COVID vaccineIndiaCOVID-19Bharat Biotech
Share
Tweet
SendShareSend
✮ Subscribe Organiser YouTube Channel. ✮
✮ Join Organiser's WhatsApp channel for Nationalist views beyond the news. ✮
Previous News

PM Modi inaugurates Pragati Maidan Integrated Transit Corridor project in Delhi

Next News

Lok Sabha speaker Om Birla completes 3 years in office; Lok Sabha saves Rs 668.86 crore

Related News

MSV Faize Noore Oliya, sank off Yemen after being hit by a projectile, but all 13 Indian nationals aboard were safely rescued

“All 13 Indian nationals have been rescued”: MEA after Indian vessel sinks off Yemen after attack

India-China border trade resumes after 6 years; Himalayan routes of Nathu La, Shipki La & Lipulekh signal reset in ties

West Asia Conflict: Stranded Sikhs in Iran land in India; Express gratitude to PM Modi and MEA for safe evacuation

Representative Image

Youth Power: Not anyone’s pawn, but the engine of a developed India

India's Ambassador to China Vikram Doreswami interacted with the Indian diaspora during the Open House event(File Photo)

Indian diaspora in China flags anti-India hate & abuse on social media; Embassy reaffirms to counter misinformation

As per the reports, Russia is considering to settle payments with Bangladesh via Indian rupees

Russia Pushes Rupee trade with Bangladesh to bypass US sanctions; A leverage for Indian currency in cross-border trade

Load More

Latest News

The Indian Silambam team, which won 29 medals at the International Open Championship in Malaysia, arrives in Chennai

Silambam Glory on Global Stage: Team India Clinches 29 Medals Ancient Martial Art wins applause at Int’l championship

Tamil Nadu: Hindu Munnani slams TVK Budget over Quaide Milleth award and Jerusalem subsidy

Former Bangladesh PM Sheikh Hasina

Former Bangladesh PM Sheikh Hasina at FCC Delhi: ‘Whatever fate awaits me, will return to my people’ – Full Speech

Central Sanskrit University Signs MoU with Thailand's Silpakorn University to Promote Sanskrit and Indian Knowledge System

Central Sanskrit University signs MoU with Thailand’s Silpakorn University to expand Sanskrit studies globally

Zuckerberg Apologises Over PM Modi Video, Meta Faces Fresh Scrutiny

Meta under fire over content manipulation: Mark Zuckerberg apologises over PM Modi video row, CSAM & deepfake lapses

The Amritsar arrests expose a troubling new face of proxy warfare, low-cost, digitally recruited and built around vulnerable young recruits (AI generated image)

Amritsar Arrests Expose the New Face of Proxy War: Petrol bombs, online handlers & vulnerable teen recruits

CPM cadre convicted by Court

Keralam: CPM cadres get 16-year jail term for bid to murder RSS karyakartas in 2018 Panoor case

Tamil Nadu Finance Minister N. Marie Wilson presented the first Budget of the TVK government in Assembly on August 5, 2026

Tamil Nadu: TVK’s first Budget projects Rs 16,000 crore additional revenue, announces welfare push

India’s global crackdown on fugitives has intensified, with 274 offenders brought back from 36 countries since 2019 (AI generated image)

From Vijay Mallya to Tahawwur Rana: India’s global pursuit of fugitives brings 274 offenders back from 36 countries

SDPI National General Secretary Riyaz Parangipete

Karnataka Hate Speech Case: SDPI’s Riyaz Parangipete convicted in 11-year-old case, PFI links back in focus

Load More
  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

  • Home
  • Search Organiser
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Africa
    • North America
    • South America
    • Europe
    • Australia
  • Editorial
  • Operation Sindoor
  • Opinion
  • Analysis
  • Defence
  • Culture
  • Sports
  • Business
  • RSS @ 100
  • Entertainment
  • More ..
    • Sci & Tech
    • Vocal4Local
    • Special Report
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Health
    • Politics
    • Law
    • Economy
    • Obituary
  • Subscribe Magazine
  • Read Ecopy
  • Advertise
  • Circulation
  • Careers
  • About Us
  • Contact Us
  • Policies & Terms
    • Privacy Policy
    • Cookie Policy
    • Refund and Cancellation
    • Terms of Use

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies